British Patient Capital states that it has pledged €25 million to Finch Capital’s Europe Fund III. The Fund is now closed.
Finch Capital is the UK and Netherlands-based VC firm. This Fund will focus on European Fintech firms that are deemed to have solid growth potential
British Patient Capital is a commercial subsidiary of the British Business Bank, the UK government’s economic development bank. Launched in 2018, British Patient Capital holds a mission to enable long-term investment in innovative firms led by entrepreneurs who aim to build large-scale businesses. This is British Patient Capital’s first commitment to a dedicated Fintech fund.
The Fund seeks to invest €2 million to €10 million per company, acquiring significant minority stakes in businesses with €2 million to €10 million in revenues. Finch plans to back 15-20 European start-ups with an expectation to gain liquidity in three to five years.
Catherine Lewis La Torre, CEO of British Patient Capital, commented on the investment:
“The UK has been a world-leader in financial services for decades and is now leading the fintech revolution. Fostering innovation across the UK, and supporting innovation-led businesses, is vital to empowering our economy. With fintech now accounting for around half of all technology deal flow in Europe, investing in Finch Capital’s Europe III fund provides a great opportunity to back companies leading in the sector. We are excited to work with Finch Capital as they continue to grow their presence in the UK and back the best UK and European growth stage fintech companies.”
